Guangdong Transtek Medical Electronics Co., Ltd (300562.SZ)
CNY 16.27
(-6.92%)
CNY 16.27
(-6.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 74.37 Million CNY | 67.72% |
| 2022 | -5.2 Million CNY | 3.6% |
| 2021 | 23.55 Million CNY | -57.77% |
| 2020 | 90.38 Million CNY | 80.04% |
| 2019 | 56.63 Million CNY | 8.28% |
| 2018 | 51.01 Million CNY | 24.55% |
| 2017 | 35.63 Million CNY | -54.95% |
| 2016 | 82.62 Million CNY | 21.91% |
| 2015 | 63.61 Million CNY | 19.16% |
| 2014 | 56.33 Million CNY | 28.88% |
| 2013 | 45.23 Million CNY | 25.39% |
| 2012 | 34.54 Million CNY | 66.46% |
| 2011 | 23.41 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 20.38 Million CNY | 28.92% |
| 2024 Q3 | 16.76 Million CNY | -44.65% |
| 2024 Q1 | 19.2 Million CNY | -12.58% |
| 2023 FY | - CNY | 67.72% |
| 2023 Q4 | 22.76 Million CNY | 274.16% |
| 2023 Q3 | 6.08 Million CNY | -70.28% |
| 2023 Q2 | 20.47 Million CNY | 271.81% |
| 2023 Q1 | -11.91 Million CNY | 33.29% |
| 2022 Q4 | -17.86 Million CNY | -201.47% |
| 2022 Q1 | -5.13 Million CNY | 79.26% |
| 2022 FY | - CNY | 3.6% |
| 2022 Q2 | 14.36 Million CNY | 379.55% |
| 2022 Q3 | 17.6 Million CNY | 22.51% |
| 2021 FY | - CNY | -57.77% |
| 2021 Q2 | 9.3 Million CNY | 27.22% |
| 2021 Q3 | 22.13 Million CNY | 138.01% |
| 2021 Q4 | -24.78 Million CNY | -211.94% |
| 2021 Q1 | 7.31 Million CNY | -57.65% |
| 2020 Q4 | 17.26 Million CNY | -42.4% |
| 2020 Q3 | 29.97 Million CNY | 32.96% |
| 2020 Q2 | 22.54 Million CNY | 360.51% |
| 2020 Q1 | 4.89 Million CNY | -29.13% |
| 2020 FY | - CNY | 80.04% |
| 2019 Q3 | 18.77 Million CNY | 69.46% |
| 2019 FY | - CNY | 8.28% |
| 2019 Q2 | 11.07 Million CNY | 1967.41% |
| 2019 Q1 | -593.17 Thousand CNY | -107.85% |
| 2019 Q4 | 6.9 Million CNY | -63.2% |
| 2018 Q1 | -3.79 Million CNY | -113.56% |
| 2018 FY | - CNY | 24.55% |
| 2018 Q2 | 12.58 Million CNY | 431.94% |
| 2018 Q3 | 13.37 Million CNY | 6.23% |
| 2018 Q4 | 7.55 Million CNY | -43.5% |
| 2017 Q3 | 16.84 Million CNY | 192.61% |
| 2017 FY | - CNY | -54.95% |
| 2017 Q1 | 5.06 Million CNY | 101.03% |
| 2017 Q2 | -18.19 Million CNY | -459.27% |
| 2017 Q4 | 27.96 Million CNY | 65.98% |
| 2016 Q3 | 27.5 Million CNY | 13.05% |
| 2016 FY | - CNY | 21.91% |
| 2016 Q1 | 15.24 Million CNY | 104.05% |
| 2016 Q2 | 24.32 Million CNY | 59.62% |
| 2016 Q4 | -490.63 Million CNY | -1883.89% |
| 2015 FY | - CNY | 19.16% |
| 2015 Q1 | 7.67 Million CNY | -44.05% |
| 2015 Q4 | -376.79 Million CNY | 0.0% |
| 2014 Q1 | 13.19 Million CNY | 0.0% |
| 2014 Q3 | 13.71 Million CNY | 3.93% |
| 2014 Q4 | 13.71 Million CNY | 0.0% |
| 2014 FY | - CNY | 28.88% |
| 2014 Q2 | 13.19 Million CNY | 0.0% |
| 2013 FY | - CNY | 25.39% |
| 2012 FY | - CNY | 66.46% |
| 2011 FY | - CNY | 0.0% |